Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled to present at the 13th Annual Wells Fargo Healthcare Conference at the Westin Copley Place in Boston, Massachusetts on Thursday, September 6, 2018.
Michael A. Mussallem, Edwards Lifesciences’ chief executive officer, is scheduled to speak to conference attendees at 8:00 a.m. ET. A live webcast of the company discussion will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com. Following the discussion, an archived version of the webcast will be available on the Edwards investor relations website in the News and Events section, and via the Edwards Lifesciences Investor Relations App for mobile devices.